Patents Assigned to Prosit Sole Biotechnology (Beijing) Co, Ltd
  • Fusion polypeptides and methods of use
    Patent number: 11242371
    Abstract: Disclosed are fusion polypeptides comprising fragments from a first and a second isoform of an interferon lambda family, nucleic acids encoding the fusion polypeptides, and vectors and host cells containing the same, and methods of making and using such compositions in treatment of interferon lambda-related diseases, disorders, and conditions.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: February 8, 2022
    Assignee: Prosit Sole Biotechnology (Beijing) Co, Ltd
    Inventors: Hongyu Liu, Mingzhi Zhao, Hetong Sun
  • Fusion polypeptides and methods of use
    Patent number: 11020454
    Abstract: Provided are fusion polypeptides comprising fragments from a first and a second FGF family member, nucleic acids encoding the fusion polypeptides, vectors and host cells containing the same, and methods of making and using such compositions in the treatment of FGF-related diseases, disorders, and conditions.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: June 1, 2021
    Assignee: PROSIT SOLE BIOTECHNOLOGY (BEIJING) CO. LTD
    Inventors: Hongyu Liu, Mingzhi Zhao, Hetong Sun
  • Fusion polypeptides and methods of use
    Patent number: 10246501
    Abstract: Disclosed are fusion polypeptides comprising fragments from a first and a second isoform of an interferon lambda family, nucleic acids encoding the fusion polypeptides, and vectors and host cells containing the same, and methods of making and using such compositions in treatment of interferon lambda-related diseases, disorders, and conditions.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: April 2, 2019
    Assignee: Prosit Sole Biotechnology (Beijing) Co, Ltd
    Inventors: Hongyu Liu, Mingzhi Zhao, Hetong Sun